Form 4: U.S. Physical Therapy CFO Carey Hendrickson Receives Stock Grants
SEC Form 4
Carey Hendrickson, CFO of U.S. Physical Therapy, received 8,100 shares of restricted stock on February 26, 2024, according to a Form 4 filing.
Summary
- Carey Hendrickson, the Chief Financial Officer of U.S. Physical Therapy, received 8,100 shares of restricted common stock on February 26, 2024.
- These shares were granted under the company's Amended and Restated 2003 Stock Incentive Plan.
- The restrictions on these shares will lapse in 15 equal quarterly installments, beginning with 506 shares vesting on April 1, 2024.
- Subsequent installments of 506 shares will vest on April 1, July 1, October 1, and January 1 of each year, with a final installment of 510 shares vesting on January 1, 2028, contingent upon continued employment.
- Following the reported transaction, Hendrickson beneficially owns 22,986 shares of U.S. Physical Therapy stock, inclusive of previously granted restricted shares.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. The sentiment is neutral to slightly positive.
Positives
- The stock grant aligns the CFO's interests with those of the company and its shareholders.
- The vesting schedule incentivizes continued employment and contribution to the company's success.
Risks
- The value of the restricted stock is subject to the performance of U.S. Physical Therapy's stock price.
- The vesting of the shares is contingent upon continued employment, creating a potential risk if the CFO were to leave the company.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's financial performance or future outlook.
Industry Context
Stock grants are a common practice in the healthcare industry to incentivize and retain key executives. The vesting schedule is designed to align the executive's interests with the long-term performance of the company.
Comparison to Industry Standards
- Stock grants to executives are a standard practice across publicly traded companies, including those in the healthcare sector.
- Companies like Encompass Health and Select Medical Holdings also utilize stock options and restricted stock units as part of their executive compensation packages.
- The size and vesting schedule of the grant are generally determined based on factors such as the executive's role, performance, and industry benchmarks.
Stakeholder Impact
- Shareholders may view the stock grant positively as it incentivizes the CFO to contribute to the company's long-term success.
- Employees may see the grant as a sign of the company's commitment to its leadership team.
Key Dates
| Date | Description |
|---|---|
| 02/26/2024 | Date of stock grant transaction |
| 04/01/2024 | First vesting date for 506 shares |
| 07/01/2024 | Second vesting date for 506 shares |
| 10/01/2024 | Third vesting date for 506 shares |
| 01/01/2025 | Fourth vesting date for 506 shares |
| 01/01/2028 | Final vesting date for 510 shares |
| 02/28/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.